Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a vaccine therapy for advanced melanoma (stages IIB/IIC/III/IV) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Melanoma
• Melanoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Intraocular Melanoma, Melanoma (Skin) | Phase 1 | Status: COMPLETED | Results posted: 2017-03-16